STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study) - Contacts and Locations

STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)

This study has been completed.
Information provided by Sanofi-Aventis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00124332

Locations


United States, Ohio
	The Cleveland Clinic Foundation
	Cleveland, Ohio, United States, 44195

Australia
	sanofi-aventis, Australia
	Macquarie Park, Australia

Belgium
	sanofi-aventis, Belgium
	Diegem, Belgium

Canada
	Sanofi-Aventis Administrative Office
	Laval, Canada

France
	sanofi-aventis, France
	Paris, France

Italy
	sanofi-aventis Italy
	Milano, Italy

Netherlands
	sanofi-aventis, Netherlands
	Gouda, Netherlands

Poland
	sanofi-aventis Poland
	Warszawa, Poland

Spain
	sanofi-aventis Spain
	Barcelona, Spain

Sponsors and Collaborators

Sanofi-Aventis

Investigators


Study Director:	ICD CSD	Sanofi-Aventis